Cargando…
The efficacy and safety of intravesical chondroitin sulphate solution in recurrent urinary tract infections
BACKGROUND: Urinary tract infections are among the most common indications for antibiotic therapy. The emergence of resistant uropathogens indicates the need for treatment alternatives. Replenishment of the glycosaminoglycan layer of the bladder, achieved by intravesical instillation of e.g. chondro...
Autores principales: | Rahnama’i, M. S., Javan Balegh Marand, A., Röschmann-Doose, K., Steffens, L., Arendsen, H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685912/ https://www.ncbi.nlm.nih.gov/pubmed/36424583 http://dx.doi.org/10.1186/s12894-022-01149-7 |
Ejemplares similares
-
Lower urinary tract signs and symptoms in patients with COVID-19
por: Marand, Aida Javan Balegh, et al.
Publicado: (2021) -
Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023) -
Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome
por: Downey, A, et al.
Publicado: (2015) -
Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result
por: Irkilata, Lokman, et al.
Publicado: (2015) -
Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis
por: Goddard, Jonathan Charles, et al.
Publicado: (2017)